Loading...

Vaxxinity, Inc.

VAXX•NASDAQ
Healthcare
Biotechnology
$0.00
$-0.02(-99.50%)
U.S. Market opens in 9h 39m

Vaxxinity, Inc. (VAXX) Stock Overview

Explore Vaxxinity, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2M
P/E Ratio-38.89
EPS (TTM)$-0.05
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year Target$0.00

VAXX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Vaxxinity, Inc. (VAXX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.89 and a market capitalization of 2.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-12.50%
5-Day Change
75.00%
1-Month Change
1650.00%
3-Month Change
17400.00%
6-Month Change
17400.00%
Year-to-Date (YTD) Change
5733.33%
1-Year Change
16.67%
3-Year Change
-99.18%
5-Year Change
-99.89%
All-Time (Max) Change
-99.89%

Contact Information

https://www.vaxxinity.com
254 244 5739
1717 Main Street, Dallas, TX, 75201

Company Facts

57 Employees
IPO DateNov 11, 2021
CountryUS
Actively Trading

Frequently Asked Questions